marcus evans europe conferences

7th Annual Protein Formulation Development and Drug Delivery Forum

Overcome Biologic Preformulation and Formulation Challenges, Design Efficient Processes and Models to Meet Regulatory Guidance and Drive Innovation in the Development, the Manufacturing and the Delivery of Vaccines and Biotherapeutics

6-8 June 2016
Avenida Palace Hotel, Barcelona, Spain

Conference Workshop

Apply Quality by Design Principles to Biologics Formulation Development

Workshop Moderator: Gudrun Bachmann

Company: Head of Drug Product Development -Biosimilars at Alvotech

Why You Should Attend

7th Annual Protein Formulation Development and Drug Delivery Forum

Protein formulation development is a problematic process that ultimately determines effectiveness and profitability of the final protein drug. Proteins are complex and fragile molecules which are not easy to identify, comprehend and most of all to stabilise in the long term, which are the main parameters for a drug to be accepted by regulation organization. Scientists have to think one step ahead to look at the impacts of formulation on manufacturing and drug delivery. Beside the complexity of proteins, formulation needs to be robust and count on clear processes which can guarantee quality of product, reproducibility, efficacy in fighting against targeted cells, and stability during all the process. Thanks to technical and analytical tools, protein formulation and drug delivery entered in a more efficient way of being produced. Drug deliveries, drug administration routes are also in ongoing process of innovation.

This Marcus evans forum will help delegates to give a more coherent, efficient and comprehensive view on the whole formulation process of protein, peptides and vaccines (from pre-formulation, formulation, production, manufacturing and delivery). They will benefit from case studies on major challenge as aggregates, particles, bioavailability, immunogenicity and compatibility and will learn how to minimise risks, time and cost expenditure.

Key Topics

  • Improve the design of biological formulation with automated and high-throughput solutions
  • Integrate QbD and PAT processes in drug development
  • Enhance stability process controlling aggregation
  • Improve characterization with efficient analytical tools
  • Discuss the regulatory environment around biological drug development
  • Previous Attendees Include

    • GlaxoSmithKline • Pfizer • Abbvie • Roche Biologics • UCB • Sandoz • Abbott • Baxter • Novartis Vaccines • Sanofi aventis • Boehringer Ingelheim • Medimmune • Bayer • Bristol-Myers Squibb • Genentech • Janssen Pharmaceutical • Merck & Co • Novo Nordisk • University of Cambridge

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Sponsors
    Malvern Instruments
    Visit website >>
    Unchained Labs
    Visit website >>

    Event Partners

    Practical Insights From

    Joel Richard
    Senior Vice President, Peptides Head of CMCE

    Y. John Wang, Ph.D.
    Group Leader and Principal Scientist

    Juliette Fortpied
    Expert Scientist, Head of Preclinical and High Throughput Formulation
    GSK Vaccines

    Adeline Boillon
    Group Leader Late Stage Pharmaceutical and Processing Development
    F. Hoffmann La Roche Ltd

    Gudrun Bachmann
    Head of Drug Product Development -Biosimilars

    Phil Morton
    Senior Department Manager
    Novozymes Biopharma

    Tatyana Mezhebovsky
    Senior Scientist BioFormulations Department
    Sanofi Biopharmaceuticals

    Jonas Fransson
    Director Drug Product Development, Drug Design & Development
    Swedish Orphan Biovitrum

    Click Here For Full Agenda

    Voice of Our Customers
    • “The conference was very interesting – all the topics presented have been very useful!”, Genzyme
    • “Really enjoyed the speakers & interactivity of the event!”, Ipsen
    • “One of the best meetings I’ve attended. Excellent organisation, topics and speakers”, GSK
    • “High quality agenda and fantastic speakers, I would definitely attend again”, Roche
    Latest Conference News & Resources

    Join the Discussion

    Follow on LinkedIn

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Melini Hadjitheori

    PO Box 24797
    CY-1304 Nicosia

    +357 22 849 308
    Fax: +357 22 849 394